Skip to main content
Top
Published in: Journal of Hepato-Biliary-Pancreatic Sciences 4/2009

01-07-2009 | Original article

Estimation of indocyanine green elimination rate constant k and retention rate at 15 min using patient age, weight, bilirubin, and albumin

Authors: Ga Yeong Kim, Kyun Seop Bae, Gyu Jeong Noh, Won Ki Min

Published in: Journal of Hepato-Biliary-Pancreatic Sciences | Issue 4/2009

Login to get access

Abstract

Backgrounds

We sought to estimate the indocyanine green (ICG) clearance (Cl), the elimination rate constant (k), and the retention rate at 15 min (R 15) using patient-specific covariates only.

Methods

We analyzed plasma ICG concentration data at 5, 10, and 15 min after intravenous injection of 0.5 mg/kg of ICG and 17 kinds of patient-specific covariates in 1,276 patients using NONMEM® (GloboMax LLC, Ellicott City, MD) for population pharmacokinetic modeling. The population models designed were externally validated on another dataset of 1,629 patients.

Results

The population typical value (TV) of Cl (Cl TV) and TV of volume of distribution (Vd TV) were modeled as: Cl TV (mL/min) = 117 × age (year)−0.119 × body weight (kg)0.348 × total bilirubin (mg/dL)−0.226 × albumin (g/dL)0.327. Vd TV (L) = 0.415 × body weight (kg)0.596 × albumin (g/dL)−0.292. ICG concentration at zero time (C 0) and 15 min (C 15) for R 15 (C 15/C 0 × 100) were derived from following equations. C 0 = dose/Vd TV and C 15 = C 0ek t where t = 15 min and k = Vd TV/Cl TV. Median percent prediction error and absolute prediction error in the estimated values were 18.0% and 25.6% for Cl; 6.1% and 16.5% for k; and −7.0% and 33.1% for R 15.

Conclusion

The predictive performance of ICG k was better than those of ICG Cl and R 15.
Literature
1.
go back to reference Jacob M, Conzen P, Finsterer U, et al. Technical and physiological background of plasma volume measurement with indocyanine green: a clarification of misunderstandings. J Appl Physiol. 2007;102:1235–42.PubMedCrossRef Jacob M, Conzen P, Finsterer U, et al. Technical and physiological background of plasma volume measurement with indocyanine green: a clarification of misunderstandings. J Appl Physiol. 2007;102:1235–42.PubMedCrossRef
2.
go back to reference Hemming AW, Scudamore CH, Shackleton CR, et al. Indocyanine green Cl as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515–8.PubMedCrossRef Hemming AW, Scudamore CH, Shackleton CR, et al. Indocyanine green Cl as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515–8.PubMedCrossRef
3.
go back to reference Hori T, Iida T, Yagi S, et al. K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl. 2006;12:605–13.PubMedCrossRef Hori T, Iida T, Yagi S, et al. K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl. 2006;12:605–13.PubMedCrossRef
5.
6.
go back to reference Sekimoto M, Fukui M, Fujita K. Plasma volume estimation using indocyanine green with biexponential regression analysis of the decay curves. Anaesthesia. 1997;52:1166–72.PubMedCrossRef Sekimoto M, Fukui M, Fujita K. Plasma volume estimation using indocyanine green with biexponential regression analysis of the decay curves. Anaesthesia. 1997;52:1166–72.PubMedCrossRef
7.
go back to reference Cherrick GR, Stein SW, Leevy CM, et al. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960;39:592–600.PubMedCrossRef Cherrick GR, Stein SW, Leevy CM, et al. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960;39:592–600.PubMedCrossRef
8.
go back to reference Wheeler HO, Cranston WI, Meltzer JI. Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med. 1958;99:11–4.PubMed Wheeler HO, Cranston WI, Meltzer JI. Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med. 1958;99:11–4.PubMed
9.
go back to reference Nambu M, Namihisa T. Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect. J Gastroenterol. 1996;31:228–36.PubMedCrossRef Nambu M, Namihisa T. Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect. J Gastroenterol. 1996;31:228–36.PubMedCrossRef
10.
go back to reference Ott P. Hepatic elimination of indocyanine green with special reference to distribution kinetics and the influence of plasma protein binding. Pharmacol Toxicol. 1998;83 Suppl 2:1–48.PubMedCrossRef Ott P. Hepatic elimination of indocyanine green with special reference to distribution kinetics and the influence of plasma protein binding. Pharmacol Toxicol. 1998;83 Suppl 2:1–48.PubMedCrossRef
11.
go back to reference Ott P, Bass L, Keiding S. Hepatic ICG removal in the pig depends on plasma protein and hematocrit: evidence of sinusoidal binding disequilibrium and unstirred water layer effects. Hepatology. 1997;26:679–90.PubMedCrossRef Ott P, Bass L, Keiding S. Hepatic ICG removal in the pig depends on plasma protein and hematocrit: evidence of sinusoidal binding disequilibrium and unstirred water layer effects. Hepatology. 1997;26:679–90.PubMedCrossRef
12.
go back to reference Tsubono T, Todo S, Jabbour N, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology. 1996;24:1165–71.PubMedCrossRef Tsubono T, Todo S, Jabbour N, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology. 1996;24:1165–71.PubMedCrossRef
13.
go back to reference Wahlby U, Jonsson EN, Karlsson MO. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn. 2001;28:231–52.PubMedCrossRef Wahlby U, Jonsson EN, Karlsson MO. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn. 2001;28:231–52.PubMedCrossRef
14.
go back to reference Gao L, Ramzan I, Baker AB. Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery. Anaesth Intensive Care. 2000;28:375–85.PubMed Gao L, Ramzan I, Baker AB. Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery. Anaesth Intensive Care. 2000;28:375–85.PubMed
15.
go back to reference Maruyama S, Hirayama C, Yamamoto S, et al. Hyperendothelinemia and ICG Cl in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci. 2002;47:773–7.PubMedCrossRef Maruyama S, Hirayama C, Yamamoto S, et al. Hyperendothelinemia and ICG Cl in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci. 2002;47:773–7.PubMedCrossRef
16.
go back to reference Kinoshita K, Maruo S. Population pharmacokinetic analysis of indocyanine green retention rate at 15 minutes. Rinsho Byori. 1990;38:906–10.PubMed Kinoshita K, Maruo S. Population pharmacokinetic analysis of indocyanine green retention rate at 15 minutes. Rinsho Byori. 1990;38:906–10.PubMed
17.
go back to reference Lee SG, Hwang S. How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg. 2005;12:38–43.PubMedCrossRef Lee SG, Hwang S. How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg. 2005;12:38–43.PubMedCrossRef
18.
go back to reference Beal S, Sheiner L. NONMEM User’s guides Part V. Introductory guide. San Francisco: NONMEM Project Group, University of California; 1992. Beal S, Sheiner L. NONMEM User’s guides Part V. Introductory guide. San Francisco: NONMEM Project Group, University of California; 1992.
19.
go back to reference Jonsson EN, Karlsson MO. Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999;58:51–64.PubMedCrossRef Jonsson EN, Karlsson MO. Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999;58:51–64.PubMedCrossRef
20.
go back to reference Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004;58:119–33.PubMedCrossRef Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004;58:119–33.PubMedCrossRef
21.
go back to reference Parke J, Holford NH, Charles BG. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed. 1999;59:19–29.PubMedCrossRef Parke J, Holford NH, Charles BG. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed. 1999;59:19–29.PubMedCrossRef
22.
go back to reference Shinohara H, Tanaka A, Kitai T, et al. Direct measurement of hepatic indocyanine green Cl with near-infrared spectroscopy: separate evaluation of uptake and removal. Hepatology. 1996;23:137–44.PubMedCrossRef Shinohara H, Tanaka A, Kitai T, et al. Direct measurement of hepatic indocyanine green Cl with near-infrared spectroscopy: separate evaluation of uptake and removal. Hepatology. 1996;23:137–44.PubMedCrossRef
23.
go back to reference Grygiel JJ, Ward H, Ogborne M, et al. Relationships between plasma theophylline Cl, liver volume and body weight in children and adults. Eur J Clin Pharmacol. 1983;24:529–32.PubMedCrossRef Grygiel JJ, Ward H, Ogborne M, et al. Relationships between plasma theophylline Cl, liver volume and body weight in children and adults. Eur J Clin Pharmacol. 1983;24:529–32.PubMedCrossRef
24.
go back to reference Evans WE, Relling MV, de Graaf S, et al. Hepatic drug Cl in children: studies with indocyanine green as a model substrate. J Pharm Sci. 1989;78:452–6.PubMedCrossRef Evans WE, Relling MV, de Graaf S, et al. Hepatic drug Cl in children: studies with indocyanine green as a model substrate. J Pharm Sci. 1989;78:452–6.PubMedCrossRef
25.
go back to reference Erdogan D, Heijnen BH, Bennink RJ, et al. Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green Cl test. Liver Int. 2004;24:117–23.PubMedCrossRef Erdogan D, Heijnen BH, Bennink RJ, et al. Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green Cl test. Liver Int. 2004;24:117–23.PubMedCrossRef
26.
go back to reference Mizuguchi T, Katsuramaki T, Nobuoka T, et al. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg. 2004;28:971–6.PubMedCrossRef Mizuguchi T, Katsuramaki T, Nobuoka T, et al. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg. 2004;28:971–6.PubMedCrossRef
27.
go back to reference Ryeom HK, Kim SH, Kim JY, et al. Quantitative evaluation of liver function with MRI using Gd-EOB-DTPA. Korean J Radiol. 2004;5:231–9.PubMedCrossRef Ryeom HK, Kim SH, Kim JY, et al. Quantitative evaluation of liver function with MRI using Gd-EOB-DTPA. Korean J Radiol. 2004;5:231–9.PubMedCrossRef
28.
go back to reference Fujioka H, Kawashita Y, Kamohara Y, et al. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol. 1999;28:329–33.PubMedCrossRef Fujioka H, Kawashita Y, Kamohara Y, et al. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol. 1999;28:329–33.PubMedCrossRef
29.
go back to reference Merkel C, Gatta A, Zoli M, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG Cl in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci. 1991;36:1197–203.PubMedCrossRef Merkel C, Gatta A, Zoli M, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG Cl in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci. 1991;36:1197–203.PubMedCrossRef
30.
31.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.PubMedCrossRef Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.PubMedCrossRef
32.
go back to reference Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.PubMedCrossRef Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.PubMedCrossRef
33.
go back to reference Furrer K, Deoliveira ML, Graf R, et al. Improving outcome in patients undergoing liver surgery. Liver Int. 2007;27:26–39.PubMedCrossRef Furrer K, Deoliveira ML, Graf R, et al. Improving outcome in patients undergoing liver surgery. Liver Int. 2007;27:26–39.PubMedCrossRef
Metadata
Title
Estimation of indocyanine green elimination rate constant k and retention rate at 15 min using patient age, weight, bilirubin, and albumin
Authors
Ga Yeong Kim
Kyun Seop Bae
Gyu Jeong Noh
Won Ki Min
Publication date
01-07-2009
Publisher
Springer Japan
Published in
Journal of Hepato-Biliary-Pancreatic Sciences / Issue 4/2009
Print ISSN: 1868-6974
Electronic ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-009-0097-3

Other articles of this Issue 4/2009

Journal of Hepato-Biliary-Pancreatic Sciences 4/2009 Go to the issue